Corticosteroid-SparingEffect ofIntravenousImmunoglobulinTherapy inPatientsWithPemphigusVulgaris NaveedSami,MD;AnsaQureshi,MD;EleonoraRuocco,MD;A.RazzaqueAhmed,MD,DMSc Background:Pemphigusvulgaris(PV)isarare,poten- tiallyfatalautoimmunemucocutaneousblisteringdis- ...
内容提示: Corticosteroid-Sparing Effectof Intravenous Immunoglobulin Therapyin Patients With Pemphigus VulgarisNaveed Sami, MD; Ansa Qureshi, MD; Eleonora Ruocco, MD; A. Razzaque Ahmed, MD, DMScBackground: Pemphigus vulgaris (PV) is a rare, poten-tially fatal autoimmune mucocutaneous blistering dis...
Successful Corticosteroid-Sparing Effect of Rituximab in the Treatment of Refractory Idiopathic Orbital Inflammatory DiseaseRituximabIdiopathic orbital inflammatory diseaseIdiopathic orbital inflammatory disease (IOID) is an idiopathic inflammatory process within the orbit that can result in permanent visual ...
Other benefits of IVIg therapy are that (1) it also has a corticosteroid-sparing effect; (2) it can be used as monotherapy; (3) it is relatively safe compared with systemic corticosteroid therapy; and (4) in addition to controlling PV, it can induce a sustained clinical remission. Further...
To demonstrate the corticosteroid-sparing effect of intravenous immunoglobulin (IVIg) therapy in patients with moderate to severe PV. A retrospective analysis in a cohort of 15 patients with moderate to severe PV who were treated with IVIg therapy. All 15 patients were corticosteroid dependent, and ...
1172 Briefcommunications skin, In the four previously reported cases of this associ- ation, PRY preceded Sweet's syndrome; in our patient it was possible to makea retrospective diagnosis ofPRY of 2 years' duration, The male predominance (four of five cases, including our patient) issimilarto...
Altogether, in this propensity score-matching model as shown by model 1 and supported by model 2, cetirizine and montelukast have suggested for the first time the corticosteroid sparing effect in allergy concomitant MCNS patients. In clinical settings, we occasionally encountered seasonal recurrence of...
School of Medicine, Showa University, 1-5-8 Hatanodai Shinagawa-ku, Tokyo, 142-8666, Japan, Tel +81 3-3784-8000, Fax +81 3-3784-8517, Email tanakaa@med.showa-u.ac.jp Purpose: The oral corticosteroid (OCS)-sparing effect of several biologics (BIOs) has been shown in clinical trials...
MPS is an effective steroid-sparing drug for the treatment of CRU. The effect seen was not only during the 6 months of therapy, but also extended to 12 months to maintain BCVA and inflammation control. The side effects were acceptable....
Nair P, Wenzel S, Rabe KF,et al, on behalf of the ZONDA trial investigators. Oral glucocorticoid–sparing effect of benralizumab in severe asthma.N Engl J Med2017; 376: 2448-2458. Wenzel S. Severe asthma in adults.Am J Respir Crit Care ...